| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |